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The hypervariable V3 loop within gp120 of human immunodeficiency virus type 1 (HIV-1) is the major determinant of cell
tropism and the entry coreceptor usage of the virus. However, the information obtained thus far has been from only subtype
B from North America and Europe, and little is known about other subtypes whose V3 amino acids differ by as much as 50%
from subtype B V3. In this study, we examined the functional potential of the V3 element of the HIV-1 subtype E, the most
crucial variant causing the AIDS epidemic throughout southeast Asia. A panel of HIV-1LAI recombinants was constructed by
the overlap extension method, by which the LAI V3 loop was precisely replaced by that of the subtype E nonsyncytium-
inducing (NSI) or syncytium-inducing (SI) variant. All of the recombinant viruses infected peripheral blood mononuclear cells,
whereas only those with SI V3 infected MT2 cells, a CD41 T cell line. Consistently, the SI V3 recombinants used CXCR4, while
the NSI V3 recombinants used CCR5 for infection of HOS-CD41 cells. Finally, only the NSI V3 sequence conferred
CC-chemokine sensitivity on the parental virus. The data support the notion that the HIV-1 V3 loop consists of a relatively
independent domain in gp120 and suggest that the subtype E V3 loop indeed contains the functional element to dictate the
cell tropism, coreceptor preference, and chemokine sensitivity of the virus. These findings are of immediate importance in
understanding V3 structure–function relationship and for examining phenotypic evolution of HIV-1 subtype E. © 1999 Academic
Press1
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Human immunodeficiency virus type 1 (HIV-1) strains
irculating in different geographic locations are classi-
ied into multiple genetic subtypes (A to H, and O),
rimarily on the basis of the sequence variation of the
ag and env genes (Myers et al., 1996). Each subtype
epresents a distinct viral quasispecies that has main-
ained its genetic identity within a fixed distance to the
ubtype consensus since the early 1980s (Lukashov et
l., 1995). However, it is controversial whether there are
ctually any biological differences between the individ-
al subtypes (Soto-Ramirez et al., 1996; Dittmar et al.,
997; Pope et al., 1997). While the epidemic and genetic
nformation for the subtype has been accumulating rap-
dly, functional studies of the important gene or protein
lements have been limited to subtype B from North
merica and Europe, and only a few studies have been
eported for other subtypes (Montano et al., 1997, 1998).
The third variable (V3) loop within the subtype B en-
elope gp120 subunit, consisting of 35 amino acids
lanked by two cysteines for a disulfide bond, is the major
eterminant of cell tropism (de Jong et al., 1992a,b; Shar-
less et al., 1992; Shioda et al., 1992; Westervelt et al.,
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (81-3) 52851177. E-mail: hirosato@nih.go.jp.491992) and entry coreceptor specificity (Choe et al., 1996;
peck et al., 1997; Cho et al., 1998). Despite its functional
onstraints, the V3 sequence is highly diverse (Myers et
l., 1996), probably because this region is immunogenic
nd subjected to the immune-pressure-mediated posi-
ive selection (Simmonds et al., 1990; Bonhoeffer et al.,
995; Seibert et al., 1995). Changes in the V3 sequence
uring disease progression are often associated with
hanges in the cell tropism and coreceptor specificity of
he virus. In the early stages of infection, nonsyncytium-
nducing (NSI), CCR5-using variants with the relatively
omogeneous V3 loop element are predominant (Chese-
ro et al., 1992; Milich et al., 1993; Scarlatti et al., 1997).
yncytium-inducing (SI), CXCR4-using variants possess-
ng the V3 loop element with multiple basic substitutions
enerally appear in the later stages of infection (Ters-
ette et al., 1988; Fouchier et al., 1992; Kuiken et al.,
992; Milich et al., 1993; Scarlatti et al., 1997). The phe-
otype switch appears to be a key event during the
isease progression of infected individuals (Tersmette et
l., 1989; Schuitemaker et al., 1992; Koot et al., 1996;
onnor et al., 1997). Thus, subtype B V3 loop is an unique
rotein element in that it is functionally important, hyper-
ariable, and related to the HIV-1 pathogenesis.
The HIV-1 subtype E was initially identified in Thailand
n the early 1990s (McCutchan et al., 1992; Ou et al., 1993)
nd is now causing an explosive epidemic of HIV-10042-6822/99 $30.00
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492 SATO, KATO, AND TAKEBEnfection throughout southeast Asia (Weniger et al., 1994;
assol et al., 1996; Menu et al., 1996; Nerurkar et al.,
996; Kusagawa et al., 1998; Loue et al., 1998; Kusagawa
t al., 1999). As has been seen in subtype B, subtype E
an be subclassified phenotypically into two groups, the
SI/CCR5 and SI/CXCR4 variants (De Wolf et al., 1994; Yu
t al., 1995; Zhang et al., 1996, 1997; Bjorndal et al., 1997;
scherning et al., 1998; Sato et al., 1999). However, it is
ot clear whether the subtype E V3 loops are able to
ictate the NSI/SI phenotype and the coreceptor speci-
icity, because the subtype E V3 loop amino acid se-
uences differ from those of subtype B as much as 50%,
ndependent of the NSI/SI phenotype classification (Mc-
utchan et al., 1992; De Wolf et al., 1994; Ichimura et al.,
994; Yu et al., 1995; Sato et al., 1999).
To better understand the role of the subtype E V3 loop
n virus entry, we have examined here its functional
otential in determining the cell tropism and coreceptor
sage by using a panel of recombinant viruses possess-
ng the subtype E V3 loop element from either NSI or SI
ariants (Sato et al., 1999; De Wolf et al., 1994; Yu et al.,
995). We show that despite the high degree of primary
equence differences between the subtype E and B V3
oops, the subtype E NSI V3 loop is able to direct the
SI/CCR5 phenotype, while the subtype E SI V3 loop can
ictate the SI/CXCR4 phenotype in the context of a sub-
ype B virus.
RESULTS
election of V3 loop sequences for recombinant
onstruction
V3 loop sequences of two subtype B (LAIV3 and
D8V3) and four subtype E strains (TH09V3, NH2V3,
H005V3, and NH1V3) were chosen to generate recom-
inants. LAIV3 and AD8V3 were included to check
hether our cloning system would not introduce
hanges in biological properties of the parental clone
nd whether the subtype B NSI V3 loop could confer an
T
V3 Loop Amino Acid Sequences Used fo
ID of V3 loop V3 loop amino acid sequences
LAI CTRPNNNTRKSIRIQR GPGR AFVTIGKI–GNMR
LAIV3 ................ .... .......–.....
AD8V3 ............H.–– .... ..Y.T.D.I.DI.
TH09V3 ....S....T..T.–– ...Q V.YRT.D.I.DI.
NH2V3 ....S....T..T.–– ...Q VWYRT.D.T..I.
KH005V3 ....SDI..I.T.I–– .... V.YKT.N.L.DI.
NH1V3 ....F..R.TR.TM–– .... VWYRT.E.V.DI.
a Determined by phylogenetic analysis of the envelope C2/V3 gene s
999).
b The number of positively charged amino acids (R and K) minus the
c MT2 phenotype of virus isolates from which V3 loop sequences arSI phenotype to the SI virus, respectively. TH09V3 was
hosen as a representative of the subtype E NSI se-
uence because it was identical to the subtype E NSI V3
onsensus made from 21 subtype E NSI isolates from
hailand (De Wolf et al., 1994; Ichimura et al., 1994).
H2V3 was selected as a representative of the naturally
ccurring V3 loops of subtype E NSI variants in an
symptomatic carrier (NH2), and the sequence com-
osed the major population in uncultured peripheral
lood mononuclear cells (PBMCs) and the NSI virus
solate from the individual (Sato et al., 1999). Due to the
igh sequence diversity of the subtype E V3 loops from
I variants, KH005V3 and NH1V3 were randomly chosen
rom a sequence pool from subtype E SI isolates (Yu et
l., 1995) and from uncultured PBMCs of an AIDS patient
NH1) carrying the SI virus (Sato et al., 1999), respec-
ively.
tructural characteristics of the selected subtype E
3 loops
The V3 loop amino acid sequences used to generate
he recombinants were compared with that of the paren-
al LAI (Table 1). The central GPG core motif in the V3
oop was retained for all of the V3 loops used in this
tudy, while the flanking sequence was highly diverse. In
articular, the downstream sequence of the GPG core
otif showed a high degree of variation. V3 loops from
ubtype E NSI variants (TH09V3 and NH2V3) and sub-
ype E SI variants (KH005V3 and NH1V3) showed about
0 and 50% amino acid identities to LAIV3, respectively.
egardless of the genetic subtype, the net positive
harge was constantly higher in the SI than in the NSI V3
oops (Table 1, net charge).
The subtype E V3 loop sequences were compared
ith the subtype E NSI V3 consensus deduced from 21
ubtype E NSI isolates from Thailand (De Wolf et al.,
994; Ichimura et al., 1994) (Table 2). TH09V3 and NH2V3
ad no basic substitutions, while KH005V3 and NH1V3
ontained three basic substitutions. A basic amino acid
tructing Recombinant HIV-1LAI Viruses
Genetic subtypea Net chargeb MT2 phenotypec
B 18 SI
B 18 SI
B 13 NSI
E 13 NSI
E 14 NSI
E 15 SI
E 16 SI
ces (De Wolf et al., 1994; Yu et al., 1995; Myers et al., 1996; Sato et al.,
er of negatively charged amino acids (D and E) in the V3 loop.
nated (De Wolf et al., 1994; Yu et al., 1995; Sato et al., 1999).ABLE 1
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493HYPERVARIABLE V3 LOOP IN gp120 OF HIV-1t position 11 in the V3 loop closely associated with SI
henotype in case of subtype B viruses (de Jong et al.,
992a; Fouchier et al., 1992, 1995) was retained only in
H1V3. A basic amino acid at position 25, another criti-
al amino acid associated with the subtype B SI pheno-
ype (de Jong et al., 1992; Fouchier et al., 1992, 1995), was
ot present in either KH005V3 or NH1V3. Finally, the
otential N-glycosylation site in the V3 loop, which is
ighly conserved in subtype E sequences from NSI iso-
ates (De Wolf et al., 1994) or in asymptomatic carriers
Sato et al., 1999; Ou et al., 1993), was retained in TH09V3
nd NH2V3, while lost in KH005V3 and NH1V3.
iological activities of the V3 recombinant viruses in
BMCs and MT2 cells
An equal amount of each recombinant DNA was trans-
ected into HeLa cells, and the culture supernatants
ere subjected to the RT assay. RT activity in the unit
olume of the transfect supernatant was similar among
he parental and recombinant viruses, peaking on days 2
nd 3 (1.5–2.0 3 104 cpm/ml culture supernatant), sug-
esting that the V3 replacement did not result in delete-
ious effects on the processing of the Gag/Pol precursor,
irion assembly, and budding (data not shown).
The supernatants containing equal amounts of RT ac-
ivity were used to infect PHA-stimulated PBMCs. The
mount of RT activity produced in the culture superna-
ants at the peak of infection was almost comparable
mong the LAIV3 control and the recombinants (Fig. 1A).
owever, the recombinant viruses replicated with differ-
nt kinetics. The recombinants with SI V3 replicated with
inetics similar to that of the LAIV3 control (Fig. 1A, left,
H005V3 and NH1V3), whereas the recombinants with
SI V3 replicated with slower kinetics than the LAIV3
ontrol (Fig. 1A, right, AD8V3, TH09V3, and NH2V3).
The six recombinants displayed marked differences in
T2-cell tropism (Fig. 1B). The LAIV3 control replicated
TABLE 2
Comparison of V3 Loop Amino Acid Sequences among Subtype E
ID V3 loop amino acid sequences
Net
charge
1 11 25 35
-NSI-ca CTRPSNNTRTSITI GPGQ VFYRTGDIIGDIRKAYC 13
H09V3 .............. .... ................. 13
H2V3 .............. .... .W......T.N...... 14
H005V3 ......DI..I.TR ...R ...K..N.L........ 15
H1V3 ....F..R..R..M ...R .W....E.V......H. 16
a Consensus made from 21 subtype E NSI isolates (De Wolf et al.,
994; Ichimura et al., 1994). A potential N-glycosylation site conserved
n the subtype E NSI variants (De Wolf et al., 1994; Ichimura et al., 1994)
s underlined. Italic letters (R and K) indicates basic amino acid sub-
titutions with respect to E-NSI-c.o a high titer on the MT2 cells (Fig. 1B, left, LAIV3), which
s consistent with the biological activity of HIV-1LAI (Pe-
en et al., 1991). Similarly, the viruses possessing sub-
ype E SI V3 loops replicated efficiently in the MT2 cells
Fig. 1B, left, KH005V3 and NH1V3). Typically, RT activi-
ies reached a peak within 5 days after infection and
iminished rapidly thereafter in repeated experiments. In
ontrast, the viruses with NSI V3 loops reproducibly
ailed to infect MT2 cells in three different experiments
Fig. 1B, right, AD8V3, TH09V3, and NH2V3).
nfectivities of the V3 recombinant viruses in
OS-CD4 cell lines
Coreceptor usage of the recombinants was assayed
y infecting the HOS-CD4 cells expressing either human
CR5 or CXCR4 (HOS-CD4-CCR5 or HOS-CD4-CXCR4)
Deng et al., 1996). The control LAIV3 virus preferentially
eplicated in HOS-CD4-CXCR4 within 7 days after infec-
ion (Fig. 2A, LAIV3), which is consistent with the core-
eptor usage of HIV-1LAI (Simmons et al., 1996). Similarly,
he recombinants with subtype E SI V3 loops replicated
referentially in the HOS-CD4-CXCR4 cells (Fig. 2A,
H1V3 and KH005V3). The tissue-culture infectious
FIG. 1. Replication of recombinant viruses in PBMCs (A) and MT2
ells (B). Virus stocks used to infect the indicated cell types were
enerated by transfecting HeLa cells with each recombinant plasmid
NA. The PHA-stimulated PBMCs or MT2 cells were infected with
upernatants containing equal amounts of reverse transcriptase (RT)
ctivity (Willey et al., 1988), and the progeny virus production was
onitored by the RT activity released into the culture medium at the
ndicated time points.
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494 SATO, KATO, AND TAKEBEoses (TCIDs) of the SI V3 recombinant viruses in the
OS-CD4-CXCR4 cells, determined by the end-point di-
ution of virus stocks, were about 25 TCID per 2 3 105
pm RT activity (data not shown). In contrast to the SI V3
ecombinants, the NSI V3 recombinant viruses uniformly
ailed to infect the HOS-CD4-CXCR4 cells and instead
rew efficiently in HOS-CD4-CCR5 (Fig. 2B, AD8V3,
H2V3, and TH09V3). These results were reproducible in
hree different experiments. TCIDs of the NSI V3 recom-
inant viruses in these cells were about 25 TCID per 2 3
05 cpm RT activity (data not shown).
ffects of CC-chemokines on infectivity of the
ecombinants
The CC(beta)-chemokines RANTES and MIP-1b are
he natural ligands of the CCR5 molecule and selectively
nhibit the infections of CD41 T cells by the HIV-1 NSI
ariants that use CCR5 (Cocchi et al., 1995; Alkhatib et
l., 1996; Deng et al., 1996; Dragic et al., 1996). The
nhibitory effect is virus-phenotype specific, and infection
f the SI, T-cell-line-tropic variants, which exclusively use
XCR4, are insensitive to these reagents (Alkhatib et al.,
996; Deng et al., 1996; Dragic et al., 1996). The critical
eterminant of the chemokine sensitivity is mapped
ithin the V3 loop (Cocchi et al., 1996).
To ascertain whether the subtype NSI V3 loop also
FIG. 2. Replication kinetics of recombinant viruses in HOS-CD4 cell
ines. HOS-CD4 cells expressing CCR5 or CXCR4 (Deng et al., 1996)
ere incubated in supernatants containing equal amounts of RT activity
or 16 h at 37°C and washed once with PBS. The progeny virus
roduction was then monitored by the RT activity released into the
ulture medium at the indicated time points. (A) Recombinants with the
I V3 loop. (B) Recombinants with the NSI V3 loop.ontains an element dictating the CC-chemokine sensi-
ivity of the virus, we examined the inhibitory effect of the
C-chemokine on the V3 recombinant and parental vi-
uses. As expected, RANTES had no effect on the infec-
ions of HOS-CD4-CXCR4 cells by the parental and two
ecombinant viruses with SI V3 up to a concentration of
000 ng/ml (Fig. 3A, LAIV3, NH1V3, and KH005V3). In
ontrast, this chemokine inhibited infections of HOS-
D4-CCR5 cells by viruses carrying subtype E NSI V3 in
dose-dependent manner (Fig. 3A, NH2V3 and TH09V3).
50% inhibitory dose of RANTES in the HOS-CD4-CCR5
ells was approximately 10 to 20 ng/ml for these recom-
inants. Unexpectedly, however, RANTES did not inhibit
he replication of AD8V3 in HOS-CD4-CCR5 cells (Fig.
A, AD8V3).
Finally, we determined whether infections of PBMCs
y the recombinant viruses were mediated by CCR5 (Fig.
B). Infectivities of the parental and two recombinant
iruses using CXCR4 (LAIV3, NH1V3, and KH005V3) were
ot affected by either RANTES (200 ng/ml) or MIP-1b
200 ng/ml). In contrast, two recombinants with subtype E
SI V3 (NH2V3 and TH09V3) were sensitive to the same
oncentration of CC-chemokines. However, both RAN-
ES and MIP-1b showed no inhibitory effect on the
eplication of the AD8V3 recombinant.
DISCUSSION
Although the crucial role of the gp120 V3 loop in HIV-1
ntry has been extensively examined through the use of
himeric viruses constructed from two viruses with dis-
inct replication phenotypes, all of these studies have
een carried out with subtype B viruses. This is partly
ecause infectious molecular clones, which make up the
enetic backbone of the recombinant, are currently avail-
ble only for subtype B. By using the subtype B clones, it
ight be difficult to obtain infectious recombinant vi-
uses having the non-subtype B V3 loop sequence be-
ause the V3 amino acids differ by as much as 50%
mong distinct subtypes. On the other hand, such recom-
inants could be viable and could therefore be used to
ssess the functional potential of the non-subtype B V3,
ecause the V3 loop consists of a relatively independent
omain in subtype B gp120 (Pollard et al., 1992; Wyatt et
l., 1993).
To examine the role of the subtype E V3 loop in virus
ntry, a panel of V3 recombinants was constructed by
sing LAI and published sequences of the subtype E V3
oop. One reason for obtaining several recombinants
as to determine whether the biological activities of the
ecombinant viruses, if any, can be correlated with those
f original subtype E isolates rather than the parental
irus. Interestingly, all of the recombinant viruses re-
ained potent infectivity on the activated primary PBMCs
nd the HOS-CD41 cells expressing the appropriate
oreceptor (Figs. 1A and 2), suggesting that V3 loop is
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495HYPERVARIABLE V3 LOOP IN gp120 OF HIV-1tructurally independent in gp120 (Pollard et al., 1992;
yatt et al., 1993). Notably, the MT2 tropism, entry core-
eptor usage, and chemokine sensitivity of the recombi-
ant viruses were consistent with the predicted proper-
ies of the original subtype E isolates rather than those of
he parental virus (Figs. 1, 2, and 3). These results
trongly suggest that the subtype E V3 loop sequence is
ompetent in subtype B gp120 and is able to direct MT2
ropism and the coreceptor preference of the virus, as
een in the subtype B V3 loop.
This in turn highlights the intriguing relationship be-
ween the diverse primary sequence and the conserved
unction of the V3 loop element. Irrespective of the ge-
etic subtype classification, NSI variants from distinct
eographic locations exclusively use CCR5 for infection,
hereas SI variants often acquire an expanded corecep-
or usage and can use either CXCR4 or CCR5 in vitro
Zhang et al., 1996; Bjorndal et al., 1997; Zhang et al.,
997; Tscherning et al., 1998; Xiao et al., 1998). However,
ue to the high degree of the V3 sequence variations, it
as not clear whether the globally diverse V3 loops
hared the ability to direct chemokine receptor prefer-
nce. The present findings provide for the first time the
xperimental evidence that the HIV-1 V3 loops have a
ommon function relatively independent of the genetic
ackbone and that there must be a conserved structure
ithin the V3 loops of the NSI/CCR5 variants or within
hose of the SI/CXCR4 variants of HIV-1.
V3 loops from the SI/CXCR4 variants share a structural
eature; i.e., an SI V3 loop has several basic substitutions
hen compared with the V3 loops from the NSI variants
f the same subtype (Table 2) (De Wolf et al., 1994). In
articular, a basic residue at position 11 or 25 is often
bserved in field isolates with the SI phenotype in sub-
ype B (Fouchier et al., 1992) and other subtypes (De Wolf
t al., 1994). While the NH1V3 used for the present study
n fact had an arginine at position 11, KH005V3 lacked
asic residues at both positions (Table 2). Nevertheless,
oth NH1V3 and KH005V3 recombinants showed a SI/
XCR4 phenotype (Figs. 1B and 2). The data suggest that
bsolute positioning of a basic residue in the V3 loop is
ispensable for the CXCR4 preference and that multiple
asic substitutions within the V3 loop may be a general
equirement for generating the SI/CXCR4 phenotype. Ex-
eriments involving site-directed mutagenesis are cur-
ently in progress to assess each of these issues.
Two mechanisms can explain the role(s) of the basic
esidues in CXCR4 recognition. First, these residues may
e involved in the direct interaction with the negatively
harged residues of the extracellular membrane domain
f CXCR4, as seen in the interaction between the V3 loop
nd negatively charged molecules (Callahan et al., 1991;
atinic and Robey, 1992; Kuipers et al., 1996). Second,
hese residues may assist in forming a particular V3
econdary structure or configuration for CXCR4 binding
Bhattacharyya et al., 1996). In either case, multiple in-eractions mediated by the several basic amino acids
long the V3 loop appear to be necessary for the V3 loop
o function, because the SI V3 loop always accompanies
everal base substitutions and not a single basic sub-
titution (Table 2) (Milich et al., 1993; De Wolf et al., 1994).
he concurrently occurring basic substitutions in vivo
ay be the result of the convergent evolution for the
bility to sustain multiple CXCR4 contacts.
There also appears to be a conserved characteristic in
he V3 loops among the NSI/CCR5 variants; i.e., an un-
harged residue at position 11 (serine/glycine) and a
egatively charged residue at position 25 (glutamic/as-
artic acid) in the V3 loop are highly conserved (Xiao et
l., 1998). Both TH09V3 and NH2V3 were observed to
ave this feature (Table 2), and the recombinants with
hese V3 loops used CCR5 and not CXCR4 for entry into
OS-CD4 cells (Fig. 2). Thus, the present results are
onsistent with the proposal of Xiao et al. (1998) that
hese residues may constitute important sites for the
CR5 preference.
Basic amino acids at positions 3 and 32, located in N-
nd C-terminal ends of the V3 loop, are highly conserved
ndependent of subtype or phenotypic classification (Ta-
le 1) (Milich et al., 1993; De Wolf et al., 1994). The high
egree of conservation throughout HIV-1 isolates indi-
ates that these residues are structurally and function-
lly constrained. They may simply be the essential resi-
ues for a loop formation or configuration in the gp120. In
ddition, the residues may participate in coreceptor rec-
gnition via a noncovalent interaction mediated by the
harged residues. In this regard, it has been suggested
he gp120–CCR5 interaction requires negatively charged
mino acids in the amino-terminal of CCR5 (Dragic et al.,
998), and the SI V3 loop can interact efficiently with
egatively charged small molecules (Callahan et al.,
991; Batinic and Robey, 1992; Kuipers et al., 1996). In the
oreceptor interaction, however, specificity to the core-
eptor binding should be generated. This may be at-
ained by the participation of other residues, such as
ther charged amino acids along the V3 loop. Thus, the
asic residues at positions 3 and 32 would not be the
nly residues involved in the coreceptor interaction, even
f they participate in the charge–charge interaction.
The observation that the recombinant virus with sub-
ype B NSI V3 (AD8V3) is not sensitive to RANTES and
IP-1b (Fig. 3) was unexpected because this virus
howed an NSI phenotype and used CCR5 for infection
Figs. 1 and 2). Such an insensitivity of the NSI/CCR5
irus to the CC-chemokines has been reported with the
equential virus isolates from an infected individual
Scarlatti et al., 1997). Interestingly, the emergence of
uch a virus during disease progression is associated
ith changes in the V3 loop sequence (Scarlatti et al.,
997). Two mechanisms could account for the insensi-
ivity. First, the binding site(s) of gp120 of these particular
trains on CCR5 had little overlap with the CC-chemo-
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496 SATO, KATO, AND TAKEBEine binding site(s) on CCR5. Second, these viruses
ould use an additional coreceptor. In the present re-
ombinant case, the available data favor the former pos-
ibility. Because the recombinant virus with AD8V3 did
ot replicate in HOS-CD4 and HOS-CD4-CXCR4 cells
Fig. 2), it is likely that the infection of HOS-CD4-CCR5
ells with this virus was mediated only by CCR5 rather
han by a presumed alternative coreceptor being ex-
ressed on the HOS cells. Furthermore, this recombinant
id not replicate in HOS-CD4 cells expressing CCR1,
CR2b, CCR3, or CCR4 (data not shown). These obser-
ations seem to argue against the second possibility.
Although two SI recombinants in our study preferen-
ially used CXCR4, SI primary isolates are often dual
ropic and can utilize CCR5 in addition to CXCR4 (Sim-
ons et al., 1996; Zhang et al., 1996; Connor et al., 1997).
here are several possible explanations for the low po-
ential for the CCR5 usage in the present SI V3 recom-
inant cases. First, the KH005 V3 sequence is derived
rom an SI virus isolate, KH005, which has been passed
n MT2 cells and has thus been selected for growth on
he T-cell line (Yu et al., 1995). Such in vitro selection
ight have caused the appearance of variants with a
ecreased potential for CCR5 usage, as seen in the
FIG. 3. Effects of CC-chemokine on the infectivities of recombinant viru
XCR4 or CCR5 were infected with the indicated viruses in the presence
ontaining the same concentration of RANTES. The percentage of the
etermined on day 7 after infection. (B) Effects on the infectivities in ac
iruses in the presence of 200 ng/ml of RANTES or MIP-1b and cultured
onitored by RT activity released into the culture medium at the indicubtype B T-cell-line-adapted strains, LAI and RF (Sim-
ons et al., 1996). Second, because the SI HIV-1 quasi-
pecies in an AIDS patient would be a mixture of variants
ith distinct levels of CCR5 preference, as seen in sub-
ype B SI primary strains (Simmons et al., 1996; Zhang et
l., 1996; Connor et al., 1997), it is possible that the clonal
H1 V3 sequence originates from a T-cell-tropic variant
ith a low potential for CCR5 usage among the various
I quasispecies in the NH1 patient. In this regard, we
ave characterized six more recombinants possessing
ther V3 sequences identified in the NH1 patient and
ave found that the variability of the SI V3 sequences in
he patient in fact yielded versatility in dictating CCR5
reference (unpublished data). Third, efficient dual us-
ge of coreceptors may require the participation of
on-V3 elements of gp120 (Cho et al., 1998), and LAI, a
-cell-line-adapted strain, may not be the ideal genetic
ackbone to provide such non-V3 element for dual us-
ge.
The present work suggests that the subtype B-based
ecombinant system provides a tool for characterizing
he biological properties of the subtype E V3 sequence
nd therefore can be used to monitor the changing
unctions of the subtype E V3 during the different stages
) Dose response in the HOS-CD4 cells. The HOS-CD4 cells expressing
reasing concentrations of human RANTES and cultured in the medium
nt of the RANTES-treated culture relative to that without RANTES was
PBMCs. The PHA-stimulated PBMCs were infected with the indicated
same concentration of CC chemokines. Progeny virion production was
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497HYPERVARIABLE V3 LOOP IN gp120 OF HIV-1f infection. As seen in subtype B infection, at least two
3 sequence lineages evolve during the disease pro-
ression of subtype E infections. A less diverse V3 loop
opulation persists independent of clinical status in as-
ociation with the presence of the NSI variant, whereas
more positively charged V3 population emerges with
isease progression and the development of SI variants
De Wolf et al., 1994; Yu et al., 1995; Sato et al., 1999).
nterestingly, the less diverse V3 population appears to
e more resistant to the positive selection pressure (Sato
t al., 1999), suggesting that the NSI/CCR5 variants may
e more resistant to the host immune pressure(s) on the
3 loop. By using the present recombinant system, we
re now assessing whether evolution of the two subtype
V3 sequence lineages is linked to evolution of the two
ajor variants, the NSI/CCR5 and SI/CXCR4 variants.
In conclusion, we have demonstrated that the subtype
V3 loop can dictate the NSI/SI phenotype and CCR5/
XCR4 preference in the context of the subtype B virus.
hese findings provide a basis for understanding the
tructure–function relationship and the phenotypic evo-
ution of the HIV-1 subtype E V3. However, additional
xperiments using subtype E infectious molecular
lones are certainly necessary to better understand the
nfection and evolution of this most crucial HIV-1 variant
n southeast Asia.
MATERIALS AND METHODS
ource of V3 loop sequences
The deduced V3 loop amino acid sequences of six
IV-1 strains (two subtype B sequences for controls and
our subtype E sequences) used in the present study are
isted in Table 1. LAIV3 was from pLAI, a subtype B
-cell-line tropic, SI infectious molecular clone (Peden et
l., 1991). AD8V3 was from pAD8, a subtype B macro-
hage tropic, NSI infectious molecular clone (Theodore
t al., 1996). TH09V3 is the V3 sequence derived from the
irus stock supernatant of HIV-1TH09 (De Wolf et al., 1994).
H005V3 was the V3 sequence derived from HIV-1KH005-
nfected MT2 cells (Yu et al., 1995). The HIV-1TH09 and
IV-1KH005 were the subtype E NSI and SI virus isolates,
espectively, from Thailand (De Wolf et al., 1994; Yu et al.,
995). NH1V3 and NH2V3 were the V3 sequences de-
ived from uncultured PBMCs of the Japanese couples,
H1 and NH2, respectively (Sato et al., 1999). The hus-
and, NH1, had developed AIDS (CDC category C3) at
he time of the PBMC collection, and the subtype E SI
irus, HIV-1NH1, was isolated from his PBMC (Sato et al.,
999). NH2, the female spouse of NH1, was asymptom-
tic (CDC category A2) at the time of the PBMC collec-
ion, and the subtype E NSI virus, HIV-1NH2, was isolated
rom her PBMCs (Sato et al., 1999).ource of an infectious molecular clone
The pLAI (Peden et al., 1991), an HIV-1 subtype B
nfectious molecular clone, was used to generate a se-
ies of full-length V3 recombinant DNA clones. The
IV-1LAI replicates efficiently in primary PBMCs and var-
ous human CD41 T-cell lines (Peden et al., 1991) and
ses CXCR4 and not CCR5 as an entry coreceptor (Sim-
ons et al., 1996).
utagenesis by the overlap extension method
Chimeric DNA segments having the subtype E V3 and
AI flanking sequences were constructed by the overlap
xtension method, as described previously (Ho et al.,
989) (see Figs. 4A and 4B). Alterations in the DNA
egment encoding the V3 loop were introduced by incor-
orating the subtype E or B nucleotide sequences of
nterest into the overlapping primers (primers 2 and 3).
riefly, two DNA fragments having overlapping ends
ere generated by polymerase chain reaction (PCR) with
he pLAI template and two sets of oligodeoxyribonucle-
tide primer pairs (primers 1 and 2 and primers 3 and 4).
hese two DNA fragments were purified by electrophore-
is, annealed with the overlapping ends, and amplified
urther by PCR with primers 1 and 4, having the StuI or
he NheI site located in the flanking regions of the LAI V3.
y using this method, only the sequences between the
wo cysteine residues flanking the V3 loop were altered.
onstruction of the full-length HIV-1 recombinant
NA clones
The StuI-to-NheI recombinant DNA fragment (456 bp)
enerated by the overlapping extension was cloned into
he StuI-to-NheI sites of pUC-LAISB, a pUC18-derived
AI subclone containing the SalI-to-BamHI fragment (2.7
b) of the pLAI. Subsequently, the SalI–BamHI fragment
f pUC-LAISB was cloned into pLAI to reconstitute a
ull-length HIV-1 molecular clone. The nucleotide se-
uences of the PCR-amplified regions (the StuI-to-NheI
ragment), as well as the sequences around all junctions
or cloning (StuI, NheI, SalI, and BamHI sites), were
erified using an ABI Prism 310 automated sequencer.
he resulting full-length HIV-1 recombinant DNA clones
ere designated pLAI-LAIV3, pLAI-AD8V3, pLAI-NH1V3,
LAI-NH2V3, pLAI-TH09V3, and pLAI-KH005V3.
ells and media for HIV infection
PBMCs were prepared from the whole blood of HIV-1
eronegative donors by Ficoll-Hypaque (Pharmacia LKB)
ensity centrifugation. Before use for infection, they were
timulated with phytohemaglutinin (PHA, 1 mg/ml) for 3
ays and grown in RPMI 1640 with 10% (v/v) heat-inac-
ivated fetal bovine serum (FBS) and 20 units/ml of re-
ombinant human interleukin-2 (rIL-2, Shionogi Pharma-
eutical Co.). MT2 cells, a human CD41 T-lymphocyte
p
b
m
m
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498 SATO, KATO, AND TAKEBEFIG. 4. Construction of pLAI-based recombinant HIV-1 DNAs that encode heterologous V3 loop sequences. (A) Construction scheme. Overlapping
rimers (2 and 3) and outer primers (1 and 4) were used to generate recombinant DNA segments having the non-LAI V3 and LAI flanking sequences
y the overlap extension method (Ho et al., 1989). The products were digested with StuI and NheI and cloned into the gp120 subclone (pUC-LAISB)
ade from pLAI (Peden et al., 1991). Subsequently, the SalI–BamHI fragment of pUC-LAISB was cloned into pLAI to reconstitute a full-length HIV-1
olecular clone. (B) Nucleotide sequences of the PCR primers used for the overlap extension. The positions of outside primers 1 and 4 are the
ucleotide numbers from the 59-end of HIV-1 LTR of pLAI (Peden et al., 1991). The V3 loop sequences within the inner overlapping primes 2 and 3
ave been highlighted with italic letters and underlined.
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499HYPERVARIABLE V3 LOOP IN gp120 OF HIV-1ell line, were grown in RPMI 1640 with 10% (v/v) FBS.
eLa cells were grown in DMEM with 10% (v/v) FBS.
D4-positive human HOS cell lines expressing human
CR5 or CXCR4 (HOS-CD4-CCR5 or HOS-CD4-CXCR4)
Deng et al., 1996) were maintained in DMEM with 10%
BS and puromycin (1.0 mg/ml).
reparation of the cell-free recombinant virus stocks
HeLa cells (5 3 105 cells) were grown in DMEM with
0% (v/v) FBS in a T25 flask for 1 day and transfected with
0 mg of the plasmid DNA using calcium phosphate
oprecipitation methods, as described previously (Peden
t al., 1991). The culture supernatants were collected at
8 or 72 h after transfection, filtered (0.45-mm pore size),
nd kept at 2152°C until use.
etection of virion production by reverse
ranscriptase (RT) assay
The RT activity of the transfect supernatants was mea-
ured in a standard assay using a poly(A) template, an
ligo(dT) primer, and a [32P]TTP substrate, as described
reviously (Willey et al., 1988).
IV infections in PBMC, MT2 cells, and HOS-CD41
ell lines
The infections were carried out in duplicate in 24-well
lates. PHA-stimulated PBMCs (2 3 106 cells), MT2 cells
2 3 105 cells), or HOS cells (2 3 105 cells) were incu-
ated in 0.1 ml of the cell-free transfect supernatant
ontaining 2–5 3 105 cpm of RT activity for 2 to 16 h at
7°C, washed once with phosphate-buffered saline
PBS), and grown in 2 ml of the corresponding medium in
4-well plates. Half of the volume of the culture medium
as replaced by fresh medium every 2 to 3 days during
he 25-day periods after infections. In all infections, a
ortion of culture supernatant was collected every 2 to 3
ays, stored at 280°C until samples were collected at all
ime points, and analyzed for RT activity.
ffects of chemokines on the infectivities of HIV
The infections were carried out in triplicate in 96-well
lates. The HOS cell lines (6 3 103 cells in 200 ml) or
HA-stimulated PBMCs (2 3 105 cells in 250 ml) were
ncubated for 30 min at room temperature in medium
ontaining various concentrations of recombinant human
ANTES or MIP-1b (R & D Systems), followed by inocu-
ation with equivalent amounts of virus normalized by RT
ctivity (2 3 105 cpm). For the HOS cell cultures, subse-
uent to overnight adsorption, cells were washed once
ith PBS and cultured in medium containing the same
oncentration of the appropriate chemokines. For PBMC
ultures, following overnight adsorption, 100 ml of the
ulture supernatant was replaced with fresh medium
ontaining the same concentration of the appropriatehemokines. In both cultures, half of the culture medium
as harvested every 2 to 3 days for RT assay and
eplaced with fresh medium containing the chemokines.
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